Remember When Provenge's Price Was Bold? Every New Cancer Drug In 2017 Cost $100,000 Or More

 
• By Jessica Merrill

The price of new oncology brands doubled in the US from 2013 to 2017, bringing the median annual price to more than $160,000 last year, up from $79,000 in 2013, according to a new IQVIA report. Spending on cancer drugs in the US has doubled since 2012, reaching nearly $50bn in 2017.

A toy train pulling a cargo of money This picture could be a reference to 'money delivery', gravy train, cargo, freight. Also, money supply and transferring money or wiring money.

More from Drug Pricing

More from Scrip